SCHEMBL4375329

SCHEMBL4375329

O=C(NSC(=O)C1Cc2ccccc2O1)Nc1cccc(OCc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NR1H4 Q96RI1 2/20 0.43
NPC1 O15118 1/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
F10 P00742 3/20 0.43
LMNA P02545 1/20 0.42
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
LTA4H P09960 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.40
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4375332 0.80 MEN1 (0.53) PDK1PDK2PDK3PDK4MEN1
SCHEMBL28390021 0.73 MEN1 (0.71) PDK1PDK2PDK3PDK4MEN1
SCHEMBL4363918 0.73 MEN1 (0.52) PDK1PDK2PDK3PDK4MEN1
SCHEMBL14136972 0.71 MEN1 (0.49) PDK1PDK2PDK3PDK4MEN1
SCHEMBL4375334 0.70 HDAC3 (0.41) NFKB1NFKB2RELAFAAH
SCHEMBL5249717 0.70 NR1H4 (0.65) PDK1PDK2PDK3PDK4MEN1
SCHEMBL7112237 0.70 HIF1A (0.54) NPC1RAB9ANFKB1NFKB2RELA
SCHEMBL14136971 0.69 MEN1 (0.54) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL4366796 0.69 NPC1 (0.58) MEN1KMT2ANPC1RAB9AF10
SCHEMBL4363934 0.69 NPC1 (0.58) MEN1KMT2ANPC1RAB9AF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US claimed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7094807-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2006-08-22 US disclosed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, SLC10A1 PDK1 2859/4885PDK2 3426/4885PDK3 3877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.